amoxigard®
ooo nita-farm, federația rusă - amoxicilina - suspensie injectabilă
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - agenți antineoplazici - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
technescan sestamibi 1 mg
mallinckrodt medical b.v. - olanda - radiofarmaceutice - trusa (kit) pt. preparate radiofarmaceutice - 1mg - aparat cardiovascular compusi cu technetium (99mtc)
technescan sestamibi 1 mg
curium netherlands b.v. - olanda - radiofarmaceutice - trusa (kit) pt. preparate radiofarmaceutice - 1mg - aparat cardiovascular compusi cu technetium (99mtc)
technescan hdp 3,0 mg
mallinckrodt medical b.v. - olanda - tc 99 m - acid oxidronic - trusa (kit) pt. preparate radiofarmaceutice - 3,0mg - sistem osos compusi cu technetium tc99
technescan lyomaa 2,0 mg
mallinckrodt medical b.v. - olanda - tc 99 m - macrosalb - trusa (kit) pentru preparate radiofarmaceutice - 2 mg - sistem respirator particule cu technetium pt. injectare
technescan hdp 3,0 mg
curium netherlands b.v. - olanda - tc 99m - acid oxidronic - trusa (kit) pt. preparate radiofarmaceutice - 3,0mg - sistem osos compusi cu technetium tc99
temelor 4 mg
medochemie ltd (ampoule injectable facility) - cipru - lorazepamum - sol. inj. - 4mg/ml - anxiolitice benzodiazepine si derivati
truxima 500 mg concentrat pentru soluţie perfuzabilă
celltrion healthcare co. ltd. - rituximabum - concentrat pentru soluţie perfuzabilă - 500 mg
rovastamed 5mg
medochemie ltd.-central factory - cipru - rosuvastatinum - compr. film. - 5mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei